Avammune Therapeutics Analysis
What is Avammune Therapeutics?
Avammune Therapeutics develops small molecule modulators targeting the innate immune system to treat cancer. The company integrates novel target biology, immunology, and computational chemistry to create a proprietary pipeline of drug candidates. Their focus includes developing best-in-class and first-in-class drugs for oncology applications.
HQ Country
Philadelphia, United States
Employees
1-10
Founded
2019
Industry
Biotech, HealthTech, Pharmaceuticals
Product Features & Capabilities
- AVA-NP-695 (ENPP1 inhibitor)
- AVA-ADR-001 (ADAR1 inhibitor)
